ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE
-
acetaminophen and
phenylephrine hydrochloride tablet, coated
AAA Pharmaceutical, Inc.
Drug Facts
Active ingredients (in each caplet) | Purpose |
---|---|
Acetaminophen 325 mg | Pain reliever/fever reducer |
Phenylephrine HCl 5 mg | Nasal decongestant |
This product contains acetaminophen. The maximum daily dose of this product is 10 caplets (3,250 mg acetaminophen) in 24 hours. Severe liver damage may occur if you take
Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin
When using this product do not exceed recommended dosage
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
adults and children 12 years and over |
|
children under 12 years |
|
colloidal silicon dioxide, croscarmellose sodium, FD&C yellow #6, hypromellose, lactose, magnesium stearate, povidone, pregelatinized starch, propylene glycol, sodium starch glycolate, stearic acid, titanium dioxide, triacetin
Distributed by:
AAA Pharmaceutical, Inc.
681 Main Street
Lumberton, NJ 08048
RESTORE u
NDC 57344-120-06
†COMPARE TO THE ACTIVE
INGREDIENTS IN SUDAFED PE®
PRESSURE + PAIN
MAXIMUM
STRENGTH
NON-DROWSY
Pressure & Pain PE
For Adults
Acetaminophen, Phenylephrine HCl
Pain Reliever/Fever Reducer, Nasal Decongestant
Relieves: • Sinus Headache • Sinus Pressure
• Sinus Congestion
FORMERLY
SINUS HEADACHE PE
24 CAPLETS
ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE
acetaminophen and phenylephrine hydrochloride tablet, coated | ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC MONOGRAPH FINAL | part341 | 12/22/2012 |
Labeler - AAA Pharmaceutical, Inc. (181192162) |